Implantable Ports Market Is Driven by Rise in Prevalence of Chronic Diseases
Rise in prevalence of chronic diseases such as cancer, diabetes, and chronic obstructive pulmonary disease, increase in product demand due to low infection rate, and new product innovation are the key factors driving the Implantable Ports Market. According to the Cancer Treatment & Survivorship, the population of cancer survivors is expected to increase to 20.3 million by 2026. An implantable venous access port has been advised as a feasible catheter for long-term use of chemotherapy and fluid administration in cancer...
View full press release